Revelation Biosciences Inc (REVB NASDAQ) stock market data APIs
$1.926
0.07(3.6%)
as of September 12, 2025
Try our APIs with
free plan!
Revelation Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Prev. Close
1.926
Open
1.9974
High
2.0049
Low
1.9177
52 wk Range
1.9-50.4
Market Cap
3 263 K
P/E Ratio
0.0022
Shares Outstanding
1 700 K
EPS
-7.01
Beta
-0.037
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Revelation Biosciences Inc data using free add-ons & libraries
Get Revelation Biosciences Inc Fundamental Data
Revelation Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -8 077 908
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-08
- EPS/Forecast: -9
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Revelation Biosciences Inc News
New
Revolution Beauty directors subscribe for 2 million new shares
LONDON - Revolution Beauty Group plc (AIM:REVB) announced Friday that two of its directors have conditionally agreed to subscribe for nearly 2 million new ordinary shares in the company. According to...
Debenhams to support Revolution Beauty fundraising, explore licensing deal
LONDON - Debenhams Group (AIM:DEBS) has committed to support Revolution Beauty Group’s conditional £15 million fundraising effort by subscribing for shares proportionate to its current 27.03% stake...
Revolution Beauty launches £1.5 million retail offer to shareholders
LONDON - Revolution Beauty Group Plc (LSE:REVB) announced on Friday a retail offer to existing shareholders to raise up to £1.5 million through the issuance of new ordinary shares priced at 3.00 penc...
Revolution Beauty raises £15 million through share placement
LONDON - Revolution Beauty Group plc (AIM:REVB) has successfully raised £15 million through a placing and subscription of new ordinary shares, the company announced Friday. The multi-channel mass be...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
